CUBE vs VYGR · P/E 25, rev $1.07B vs rev $80.0M
CubeSmart (CUBE) versus Voyager Therapeutics Inc (VYGR) — a side-by-side from cached financials, not a winner call.
CubeSmart (CUBE) is a reit - industrial company listed on US.
Voyager Therapeutics Inc (VYGR) is a biotechnology company listed on NASDAQ.
Latest reported CUBE revenue for 2024-12-31 was $1.07B. Net income was $391.9M. Revenue was up 1.5% from 2023-12-31 to 2024-12-31. CUBE currently screens at market cap $9.69B and trailing P/E 25.0.
Latest reported VYGR revenue for 2024-12-31 was $80.0M. Net income was -$65.0M. Revenue was down 68.0% from 2023-12-31 to 2024-12-31. VYGR currently screens at market cap $225.4M.
CUBE currently screens at market cap $9.69B and trailing P/E 25.0. VYGR currently screens at market cap $225.4M.
Not investment advice. Open the CUBE and VYGR stock pages for the full models.
Not investment advice.